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DOI: 10.1039/c0jm01500hHigh surface area hydroxyapatites have been explored as biocompatible supports for antibacterial
applications. Porosimetry, XRD, XPS and XAS reveal that Ag-doped mesoporous hydroxyapatite
promotes the genesis of potent Ag3PO4 nanoparticles, effective against Staphylococcus aureus and
Pseudomonas aeruginosa.Introduction
Hydroxyapatite (Ca10(PO4)6(OH)2 or HA) is a major component
of bone, and the combination of biocompatibility and structural
rigidity facilitates its use as medical support architectures within
the body as surgical implants1–3 and to aid tissue regeneration.
However, an important complication with the use of such
biomaterials is their propensity for biofilm formation, initiated
through reversible bacterial adhesion at their outer surfaces via
weak van der Waals forces.4,5 Biofilm growth can be strongly
suppressed by inhibiting this step,6 whereas once bacteria gain
this first foothold they provide an improved environment for
further bacteria adhesion, becoming irreversibly bound to each
other as well as the host surface as colonies develop, forming
a complex, toxic matrix.7 MRSA and other hospital acquired
infections are commonly spread in this manner, and have been
treated with transition metals such as Cu, Zn and Ni, known to
exhibit antibacterial properties.8,9 Silver has also long been noted
for its bactericidal nature, and it is very effective in killing
biofilms.1 The first documented use of silver in water purification
dates back to ancient Greece, where silver coins were added to
water vessels to prevent bacterial growth, while the Phoenicians
used silver jars to preserve wine and vinegar during long military
and exploratory campaigns. The first scientific papers detailing
silver’s medicinal benefits for the treatment of eye infections were
published in the 1880s, wherein dilute silver nitrate solutions
helped alleviate blindness in infants.10 Topical silver treatments
were subsequently extended to burns in 1965,11 with silver
sulfadiazine (SSD), a soluble Ag(I) complex, introduced to
reduce wound infections in 1968,12,13 an important treatment that
remains in use today. This increased awareness of silver as an
antimicrobial agent has led to the synthesis of various inorganic
Ag-containing materials including zeolites,14 resin composites,15
and glasses.16 It is generally accepted that silver’s biological
activity is associated with release of dissolved Ag+ ions,17,18
explaining the efficacy of SSD in treating skin wounds.
Silver has been incorporated into many presentation formats
with a view to improving/regulating its release rate in vivo.19–24aDepartment of Chemistry, University of York, York, UK YO10 5DD
bCardiff Catalysis Institute, School of Chemistry, Cardiff, UK CF10 3AT.
E-mail: leeaf@cardiff.ac.uk; Fax: +44 (0)2920 874778; Tel: +44 (0)2920
874778
cSincotrone Trieste, 34149 Basovizza, Trieste, Italy
† Electronic supplementary information (ESI) available: Additional
characterisation of HA materials, ZoI images and comparative
microactivity tests. See DOI: 10.1039/c0jm01500h
8056 | J. Mater. Chem., 2010, 20, 8056–8063We recently showed that simple wet-impregnation of ultra-low
silver concentrations over mesoporous alumina generated highly
dispersed (5 nm) Ag2CO3 nanoparticles with excellent antibac-
terial properties.25 However, an important issue in developing
therapeutic treatments to combat infection is the cyto/biocom-
patibility of associated dressing or device format.26,27 While
alumina is FDA-approved for various drug and prosthetic
applications, it is not widely used in wound dressings. In
contrast, HA has been widely employed to present colloidal silver
nanoparticles (7–65 nm)28–30 or form ion-exchanged, Ag-doped
HA coatings and scaffolds with antimicrobial properties.30–34
Here we apply X-ray probes to show that high area HAs offer
biocompatible, solid supports able to preferentially stabilise
Ag3PO4 nanoparticles affording tuneable Ag(I) release rates and
potent bactericidal activity.Materials and methods
Hydroxyapatite and calcium phosphate synthesis
High area hydroxyapatite (HA-H) was prepared following the
synthesis of El Hammari et al.35 Briefly, 14.96 g Ca(OH)2 was
dissolved in 200 cm3 H2O/EtOH (1 : 1 vol%), and stirred for 3 h
at 25 C. Subsequently, 13.40 g NH4H2PO4 were dissolved in
200 cm3 water and slowly added to the Ca(OH)2 solution over
24 h via dropwise addition. The pH of the slurry was monitored
throughout the precipitation reaction and reached a final value of
around 11. The slurry was then heated at 70 C under reflux and
stirring for 3 h. The resulting precipitated crystals were aged for
24 h, filtered and then calcined overnight at 100 C to give a final
bright white powder product.
Comparative low area hydroxyapatite (HA-L) was prepared
by Plasma Biotal Ltd.2 by calcining 100 g of amorphous calcium
phosphate (CAPTAL A.C.P) at 300 C for 2 h.Silver impregnation
The biocompatible supports and silver nitrate precursor (Sigma
Aldrich, >99%) were combined in an incipient wetness technique.
Slurries of the support and AgNO3 were prepared to give
nominal silver loadings of 0.05–10 wt%; 5 g of each support were
placed in a 250 cm3 beaker along with the required mass of silver
nitrate and stirred in 50 cm3 deionised water at 350 rpm for 24 h.
The resulting paste was oven dried at 100 C and then left to air
dry for a further 24 h. Samples were then heated in flowing air at
10 C min1 to 500 C and calcined for 3 h. The brilliant whiteThis journal is ª The Royal Society of Chemistry 2010
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View Onlineparent supports appeared off-white following low Ag loadings
and light sand coloured following high Ag loadings.
Physical characterisation
Elemental analysis was conducted using a Hitachi Z-5300
Polarised Zeeman AA, calibrated with silver AA standard
solutions (Aldrich, 1000 mg cm3 Ag in 1 wt% HNO3). Known
amounts of test sample were digested in warm, concentrated
HNO3 acid, and analysed in triplicate to improve accuracy.
Porosimetry was conducted on a Quantasorb Nova instrument
by N2 physisorption. Surface areas were calculated using the
BET equation over the pressure range P/P0 ¼ 0.02–0.2, where
a linear relationship was maintained, while pore-size distribu-
tions were calculated using the BJH model up to P/P0 ¼ 0.95.
Samples were degassed under vacuum at 120 C for at least 2 h
prior to analysis. Powder X-ray patterns were recorded using
a Bruker AXS D8 diffractometer equipped with a Cu Ka X-ray
source and LynxEye detector. Data were collected over
2q ¼ 20–70 with a step size of 0.02. TEM was conducted on
a Philips EM 208 instrument operating at 80 kV. Samples were
dispersed and sonicated in ethanol, and evaporated onto
continuous carbon film grids.
Ag K-edge (25.5 keV) XANES measurements were made on
the XAFS beamline of the Elettra synchrotron facility, using
a Si(111) double-crystal monochromator with a beam current/
energy of 250 mA per 2 GeV. Additional XAS measurements
were made on Station 9.3 of the Daresbury SRS using a Si(220)
double-crystal monochromator with a beam current/energy of
150 mA per 2 GeV. Transmission and fluorescence Ag K-edge
spectra were acquired on powdered samples mounted within
stainless steel washers. Silver standards were diluted with boron
nitride to achieve unit absorbance. Linear combination fitting of
the Ag-impregnated supports XANES data to Ag2O, AgO,
Ag3PO4, Ag2CO3 and Ag foil standards was undertaken with the
Athena 0.8.050 application from the IFEFFIT Open Source
software suite.36 EXAFS of HA samples and silver standards
were background subtracted and fitted using the Daresbury
Exspline and Excurv98 packages.
Dissolution kinetics
A Nico 2000 Silver Ion-Selective Electrode (ISE) was employed
for measuring dissolved Ag+ as a function of time. The electrode
was calibrated against a series of known standard solutions
spanning 5, 10, 50, 100 and 1000 ppm using silver atomic
absorption standard solutions (Aldrich, 1000 mg cm3 Ag in
1 wt% HNO3). Analyses were performed in a 0.1 M buffer
solution of NaNO3. 50 mg of Ag standard or 200 mg of Ag
supported on HA were stirred in 25 cm3 of deinionised water at
room temperature. 5 cm3 aliquots of this sample were then
periodically added to 25 cm3 of 0.1 M NaNO3 solution to
determine the Ag+ concentration from the sample. Direct
measurement in the sample beaker was not possible as the elec-
trode could not tolerate powders.
Microbiological studies
Zone of Inhibition (ZoI) plates were prepared by seeding
agar plates with a known number of bacteria (108 colonyThis journal is ª The Royal Society of Chemistry 2010forming units per cm3), and known amounts of powder
samples subsequently placed on the seeded agar. Tests were
performed against two bacterial strains, Staphyloccocus aureus
NCTC 10788 and Pseudomonas aeruginosa NCIMB 8626,
examples of Gram-positive and Gram-negative bacteria
common in chronic wounds. The test organisms were har-
vested from overnight cultures grown at 37 C on fresh
tryptone soya agar (TSA, a nutrient-rich, soyabean casein
digest agar widely used to cultivate microorganisms) slopes.
Test organisms were harvested into 9 ml Ringers solution
(containing sodium, iron and potassium) and washed twice.
The test suspensions were adjusted to give the desired
bacterial inoculum of 108 colony forming units per cm3
(cfu cm3). The colony density was confirmed by performing
10-fold serial dilutions of the test suspension to a 108 factor,
and plating the last three dilutions via the pour plate method.
In the pour plate method, 1 cm3 of the required dilution is
pipetted into Petri dishes and 20 ml TSA added. Plates are
then incubated at 37 C for 24 h to allow growth of colonies
which can be manually counted and the original bacterial
concentration thus deduced.
Zone plates were prepared by pouring 140 ml of Mueller
Hinton agar (MHA, an infusion of beef and acid hydrolysate of
casein) into a 23  23 cm assay plate. Once set, a second 140 ml
of MHA were seeded with 1.4 cm3 of the 108 cfu cm3 suspension
of chosen test organism (final concentration106 cfu ml1) which
was mixed gently and poured over the previous layer. Once this
layer had set, plates were dried at 37 C for 30 minutes with the
lid removed, and then 8 mm wells bored into the agar. The bore
was first dipped in 70% ethanol and heated to high temperature
to minimise contamination, and 8 mm agar disks removed with
a sterile micro-spatula. 200 ml of sterile water were added to each
10 mg HA sample to be tested and the slurry pipetted into wells.
Assay plates were finally sealed with lab film and incubated for
24 h at 37 C.
More quantitative Log reduction tests were also performed
with S. aureus NCTC 10788. This was harvested by the above
method to yield an inoculum of 107 cfu cm3. In duplicate, 10 mg
of Cap/Hap sample were inoculated with 0.5 ml of this inoculum
in sterile universals. These samples were incubated at 32 C for
varying intervals (24, 72 or 168 h). At each time point STS was
added, to instantly passivate any dissolved silver (validation of
neutralisation was checked using the ISE, in order to ensure that
STS would fully inhibit any antimicrobial activity arising from
soluble Ag+). The resulting solution was serially diluted to obtain
a range of countable dilutions. A baseline zero time count was
always carried out immediately following inoculation as
a double-check on the calculated log reduction. Following
incubation, colonies were counted and multiplied up by the
appropriate dilution factor to determine the original colony
count remaining in the neat sample. The log count of microor-
ganisms present at each time point can be subtracted from the log
count present at zero time to yield the log reduction. One log
reduction unit equates to a 90% decrease in the number of
bacteria; the industry standard requirement for a material to be
classified as antibacterial is three log reduction units, corre-
sponding to a 99.9% reduction in numbers of viable bacteria,
with typical household disinfectants affording >5-fold log
reduction.37J. Mater. Chem., 2010, 20, 8056–8063 | 8057
Fig. 1 Adsorption–desorption isotherms of parent HA supports.
Fig. 2 Powder X-ray diffractograms of parent HA supports, indexed
against JCPS 9-432.
Table 1 Silver content of doped HA samples
Nominal
Ag loading
(wt%)
HA-L bulka
(wt%)
HA-H bulka
(wt%)
HA-L surfaceb
(wt%)
HA-H surfaceb
(wt%)
0.05 0.07 0.05 0.16 0.13
0.5 0.29 0.31 0.43 0.34
1 0.69 0.58 0.67 0.48
2.5 1.19 1.39 1.38 1.32
5 3.03 3.27 3.23 3.48
10 6.87 5.56 6.69 6.01
a Determined by atomic absorption. b Determined by XPS.
Fig. 3 Powder X-ray diffractograms of (a) Ag–HA-L and (b) Ag–HA-H
and comparative bulk Ag3PO4 (r) and Ag metal (+) standards.
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View OnlineResults and discussion
HA supports
Physico-chemical properties of both parent supports were first
evaluated to confirm the successful synthesis of high and low area
HA. Porosimetry revealed both supports exhibited Type IV
isotherms, characteristic of micro-mesoporous solids, with
hysteresis loops indicative of cylindrical pore openings (Fig. 1).
The HA-L surface area was only 63 m2 g1, much lower than the
corresponding HA-H support, which at 204 m2 g1 is significantly
higher than previously reported for alternative nanocrystalline
HA materials.38–40 These differing HA surface areas are expected
to strongly influence subsequent silver dispersion. Pore diameters
ranged from 1–20 nm for HA-L, while HA-H exhibited a sharper
pore-size distribution, centred6.5 nm in accordance with TEM.
BJH analysis indicates around 70% of the HA-H surface area
arises from mesopores.
Powder XRD showed both HA materials were crystallo-
graphically identical (Fig. 2), matching well to literature patterns
for pure hydroxyapatite (JCPDS 9-432). HA-H possesses
a higher degree of crystallinity, associated with larger mean8058 | J. Mater. Chem., 2010, 20, 8056–8063particle diameters of 37 nm compared with 30 nm for HA-L
(estimated from peak broadening using the Scherrer equation).
The surface Ca : P atomic ratios determined by XPS were also in
line with expectations at 1.53 for both samples, slightly lower
than the theoretical value of 1.67 for pure HA, but greater than
that expected for a- and b-tricalcium phosphates and in line with
previous reports.41Structural properties of Ag-doped HA
Following the successful synthesis of HA supports of variable
surface areas, HA-L and HA-H were both doped with a series of
silver concentrations nominally between 0.05 and 10 wt%. The
resulting bulk and surface Ag loadings are given in Table 1, from
which it is evident that the similar (tuneable) silver concentra-
tions could be achieved for both HA supports without significant
silver surface segregation, indicating a uniform distribution of
Ag throughout the porous matrices.
Porosimetry (ESI†) showed negligible textural changes
following silver incorporation, although surface areas fell slightly
with increasing Ag loading giving maximal decreases of 10 m2
g1 and 50 m2 g1 for HA-L and HA-H, respectively. These
decreases likely reflect micropore blockage by Ag-containing
nanoparticles. Evidence for the latter was obtained from
complementary XRD, XPS and XAS measurements of theThis journal is ª The Royal Society of Chemistry 2010
Fig. 5 Surface concentrations of silver species derived from fitted Ag 3d
XP spectra of Ag–HA-H as a function of bulk silver loading.
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View OnlineAg-doped HAs. Fig. 3a and b compare XRD patterns of repre-
sentative Ag–HA samples and standards. No silver derived
reflections were visible below 3 wt%, consistent with formation of
highly dispersed (<3 nm) particles. TEM confirmed the presence
of uniformly distributed sub-4 nm particles. For the HA-L
sample, higher loadings resulted in weak XRD features associ-
ated with Ag3PO4 particles (45 nm mean diameter) and stronger
reflections arising from metallic silver (60 nm). These coincide
with the appearance of large (>10 nm) Ag crystallites by TEM. In
contrast, only Ag3PO4 nanoparticles were observed on the HA-H
support, with their intensity and size increasing with Ag content,
reaching40 nm for the 5.56 wt% sample. There was no evidence
for bulk silver oxides or carbonate. Silver phosphate nano-
particles have been previously observed over Ag-doped, micro-
wave synthesised HA nanowhiskers,33 and pre-formed HA
porous sinters,22 in competition with Ag+ lattice substitution for
Ca2+ ions. Here we note that higher surface area HA thus appears
to preferentially stabilise silver phosphate nanoparticles. These
observations are consistent with XPS measurements of both
series, which show surface Ag3PO4 and Ag2CO3 co-exist at high
silver loadings (Fig. 4), with the surface phosphate concentration
increasing with silver dispersion (decreasing Ag loading). There
was no evidence of surface silver metal or oxides, in contrast to
literature reports for wet impregnation of conventional, low area
(50 m2 g1) HA,42 however, good spectral fits could not be ach-
ieved without incorporating an additional high binding compo-
nent at 368.5 eV that could not be matched with any feasible bulk
silver standard. This new component may reflect either the
genesis of a new chemical environment, e.g. Ag3PO4 localised at
the support interface (initial state effects), or changes in core–
hole neutralisation efficiency arising from e.g. particle size-effects
and poorer screening of sub-10 nm Ag3PO4 clusters (final state
effects); nanoparticle silver orthophosphate is known to possessFig. 4 Fitted Ag 3d XP spectra of (left) Ag–HA-L and (ri
This journal is ª The Royal Society of Chemistry 2010unusual electronic properties.43 In either case, the loading
dependence of this new silver feature, quantified in Fig. 5 for
Ag–HA-H, suggests it is characteristic of nanostructured silver
phosphate; the corresponding C 1s spectra discount any form of
perturbed surface carbonate. The choice of HA support has little
influence upon the distribution of surface silver species, with
a common limiting composition of 65% Ag3PO4/35% nano-
Ag3PO4 attained for the highest dispersions.
XANES provided further insight into the (average) local
chemical environment of Ag atoms dispersed across the HA
supports. Fig. 6 presents normalised Ag K-edge XANES as
a function of silver loading. High loadings favour the formationght) Ag–HA-H and comparative bulk silver standards.
J. Mater. Chem., 2010, 20, 8056–8063 | 8059
Fig. 6 Normalised Ag K-edge XANES of (a) Ag–HA-L and
(b) Ag–HA-H and comparative bulk silver standards.
Fig. 8 Fitted Ag K-edge radial distribution functions for representative
Ag–HA samples.
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View Onlineof metallic silver nanoparticles over HA-L, in agreement with
XRD, with phosphate-like features only emerging at the lowest
loadings.44 While Ag metal is also observed for the 5.56 wt%
Ag–HA-H sample, these features vanish for all lower silver
loadings, which closely resemble bulk Ag3PO4.
These trends were quantified through linear combination
fitting of each Ag–HA sample to reference compounds (ESI†).
The resulting compositional analysis is shown in Fig. 7 for both
supports. All spectra fitted well to simple silver metal/phosphate
mixtures, with negligible contributions from either Ag2O, AgO
or AgCO3. While both supports show the same qualitative
behaviour, it is again evident that HA-H permits a higher
absolute concentration of Ag3PO4 nanoparticles. Detailed
EXAFS analysis (ESI†) confirmed our phase assignments,
revealing an excellent fit to fcc silver metal for high Ag loadings
on HA-L and a corresponding good fit to crystalline Ag3PO4
45
for all but the highest HA-H loading sample (representative
radial distribution functions are shown in Fig. 8a and b).
Silver dissolution kinetics for Ag-doped HA
Having discovered that the choice of HA support influences both
the dispersion and the nature of nanoparticulate silver phase, the
question arises whether these differences influence subsequentFig. 7 Average composition of (left) Ag–HA-L and (righ
8060 | J. Mater. Chem., 2010, 20, 8056–8063silver dissolution (a pre-requisite to bactericidal action). Silver
release rates were therefore assayed using an electrochemical ion-
selective electrode by measuring the increase in [Ag+] with time.
The resulting rates in Fig. 9 were derived from the initial linear
portion of the dissolution profile, and are normalised to the mass
of silver in each parent sample or reference compound for
quantitative comparison.
The correlation between silver loading and solubility is
striking; dilute Ag–HA samples release ionic silver orders of
magnitude faster than their high loading counterparts indepen-
dently of the support. This trend tracks the associated (surface
and bulk) Ag3PO4 content, with the HA-H materials, which for
any given Ag loadings contain proportionally more phosphate,
releasing Ag+ fastest. Dissolution profiles were also obtained for
related silver standards, including silver sulfadiazine (SSD),t) Ag–HA-H derived from fitted Ag K-edge XANES.
This journal is ª The Royal Society of Chemistry 2010
Fig. 9 Normalised initial rate of Ag+ dissolution as a function of bulk
silver loading for Ag–HA samples and reference standards.
Fig. 10 Normalised zones of inhibition as a function of bulk Ag loading
for Ag–HA samples.
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View Onlinewhich proved largely insoluble in the identical aqueous medium.
The poor performance of pure Ag3PO4 reflects particle size
effects (mean XRD crystallite diameter 120 nm), which result
in a very low surface area : volume ratio and thus extremely slow
dissolution. SSD is likewise sparingly soluble under our condi-
tions; its efficacy is a strong function of wound pH and the
presence of sodium salts and proteins in tissue fluid. These
dissolution rates also compare favourably with those from
mesoporous-Al2O3 supported Ag2CO3 nanoparticles
25 wherein
a maximum solubility of 1.48 ppmAg+ min
1 was observed, and
vastly exceed those observed for e.g. phosphate-based glasses
(typically 0.2 ppm h1),23,46 or polymer coatings.47Antibacterial performance
The antimicrobial activities of the Ag–HA materials were
assessed by zone plate inhibition (ZoI) and the logarithmic
reduction method against S. aureus NCTC 10788 and P. aeru-
ginosa NCIMB 8626. These represent respective Gram-positive
and -negative bacteria commonly found on the skin and in
chronic wounds.
In the zone assay method, antimicrobial efficacy is propor-
tional to the size of the colony-free zone surrounding the test
sample, where bacterial growth was inhibited. The results in
Fig. 10a and b show a strong (inverse) correlation between silver
(loading) phosphate composition and bactericidal activity for
both Ag–HA materials, with almost a 100-fold enhancement
achievable across each series. The higher area Ag–HA-H mate-
rials outperformed their Ag–HA-L counterparts (although ZoI
tests are only semi-quantitative) against both bacterial strains,
with the more resilient Gram-positive S. aureus proving harder to
inhibit. Comparative measurements for reference bulk
compounds (AgO ¼ 0.19 mm gAg1, Ag2O ¼ 0.08 mm gAg1 and
Ag2CO3¼ 0.1 mm gAg1) highlight the outstanding performance,
per mass of silver, of our HA-supported Ag3PO4 nanoparticles.
The plots in Fig. 10 exhibit two distinct loading regimes, mir-
roring the dissolution rates in Fig. 9. We associate the first
region, between 5 and 1 wt% Ag, with the phase transition fromThis journal is ª The Royal Society of Chemistry 2010metallic silver or phosphate bulk-like structures to nano-
particulate (<3 nm) Ag3PO4, and attribute the second, more
pronounced region between 1 and 0.05 wt% Ag, to decreasing
Ag3PO4 particle size and a corresponding rise in surface area and
thus enhanced solubility. By way of comparison, our best per-
forming Ag2CO3/meso-Al2O3 material gave diffusion zones of
36 mm gAg
1 (S. aureus) and 24 mm gAg
1 (P. aeruginosa),25 both
significantly lower than that observed for the lowest loading
Ag–HA-H sample in Fig 9.
Although ZoI measurements are a good indicator of antimi-
crobial activity, they do not provide quantitative bacterial kill
rates, which are far more important in e.g. wound management:
clear zones evidence bacterial inhibition but not necessarily
cytotoxicity. Quantitative log reduction kill tests were therefore
subsequently undertaken to assess the potency of Ag–HA
samples against S. aureus over 7 days. In this approach, a known
concentration of microorganisms (107 cfu ml1) was added to the
test material, and then recovered after different time periods and
cultured. Antimicrobial activity is assayed from the decrease in
viable bacteria after specific times: each increasing log10 reduc-
tion unit equates to a 90% enhanced kill rate over the preceding
value. The resulting time dependent log reductions are shown in
Fig. 11 for both HA series, alongside a range of pure silver
compounds. The first important observation is that all the
dispersed Ag–HA materials significantly outperform any of the
unsupported silver compounds. Of these latter controls, pure
Ag2CO3 and Ag3PO4 exhibited the highest antibacterial activity,
but still lagged at least 0.5 log reduction units behind the worst
performing 6.87 wt% Ag–HA-L sample. Second, activityJ. Mater. Chem., 2010, 20, 8056–8063 | 8061
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View Onlinesystematically increases with decreasing silver content over both
HA supports, in line with the silver release rates and ZoI results;
these trends were also maintained across the entire 7-day test
period. This finding is in accordance with our observations of
Ag-doped aluminas, wherein the lower the silver concentration
the higher the bactericidal efficacy. Our prediction that ‘less
precious metal ¼ improved antibacterial performance’ (per unit
mass of Ag) may have cost/benefit implications for formulating
new Ag-containing medical devices, particularly silver-based
wound dressings,48 wherein existing commercial products offer
a wide range of loadings spanning 1.6–546 mg Ag per100 cm2.49
It is worth noting that despite the excellent water solubility of
AgNO3 (ESI†), consequent high [Ag+] can drive colloidal silver
formation (often as a ‘silver mirror’), hence the exceptional
performance of our Ag–HA materials cannot be accounted for
by their fast release of Ag(I) ions alone. Some studies haveFig. 11 Normalised zones of inhibition as a function of bulk Ag loading for A
8062 | J. Mater. Chem., 2010, 20, 8056–8063postulated that colloidal silver may interact directly with path-
ogens to promote cell death.50 However, there remains little
evidence for a specific Ag-bacterial interaction, e.g. localised
accumulation of silver within cell walls or unique intracellular
compartments, with uniform bacterial decoration by silver
nanoparticles more indicative of non-specific electrostatic inter-
actions. Since we observe an inverse correlation between the
formation of metallic silver and bactericidal activity, it seems
more plausible that phosphate ions (released alongside ionic
silver) contribute to additional disruption of cellular metabolic
pathways. Fig. 11 also highlights that each Ag–HA-H sample
outperformed its analogous loading Ag–HA-L counterpart by
>0.5 log reduction units following the 7-day test, which we
attribute to a higher proportion of more highly dispersed ionic
Ag(I) species. This conclusion is supported by the relative anti-
bacterial potencies of our previous alumina-supported silverg–HA–L (top) and Ag–HA–H (bottom) samples and reference standards.
This journal is ª The Royal Society of Chemistry 2010
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View Onlinematerials,25 for which the hierarchy follows: Ag–HA-H >
Ag–mesoporous-Al2O3 > Ag–HA-L > Ag-g-Al2O3 (ESI†). High
surface area supports (HA-H or meso-alumina ¼ 204 or 350 m2
g1 respectively) thus appear to promote stabilisation of Ag(I)
nanocrystallites with respect to conventionally synthesised low
area supports (HA-L or g-alumina ¼ 204 or 180 m2 g1 respec-
tively). The better performance of nanoparticulate Ag3PO4
(stabilised on HA) versus nanoparticulate Ag2CO3 (stabilised on
alumina) is still not understood, and likely reflects a combination
of factors including support hydrophilicity/surface charge, and
influence of dissolved carbonate and phosphate counter ions on
solution pH and Ag+ solubility. We are currently developing
methods to incorporate our Ag–HA powders into more easily
processed presentation formats for clinical tests.
Conclusions
Silver impregnation of porous hydroxyapatites provides a simple
means to control the production of dispersed Ag(I) species for
antibacterial applications. The use of low surface area HA, or
high Ag loadings, generates inhomogeneous materials containing
large (>45 nm) metallic and/or phosphate particles which exhibit
slow dissolution kinetics and poor microbiological performance
against Gram-negative and -positive bacteria. High area HA, or
ultra-dilute silver loadings (<0.5 wt% Ag), preferentially stabilise
sub-3 nm pure Ag3PO4 nanoparticles with dramatically
enhanced silver release rates and corresponding bacterial kill
rates.
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